Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours

Current hormonal therapies for prostate cancer are effective initially, but inevitably tumours progress to an advanced, metastatic stage, often referred to as ‘androgen independent’. However, the androgen receptor (AR) signalling pathway is still key for their growth. It is speculated that tumours e...

Descripción completa

Detalles Bibliográficos
Autores principales: Dart, D Alwyn, Spencer-Dene, Bradley, Gamble, Simon C, Waxman, Jonathan, Bevan, Charlotte L
Formato: Texto
Lenguaje:English
Publicado: Society for Endocrinology 2009
Materias:
Regular Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782800/
https://www.ncbi.nlm.nih.gov/pubmed/19635783
http://dx.doi.org/10.1677/ERC-09-0028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782800/
https://www.ncbi.nlm.nih.gov/pubmed/19635783
http://dx.doi.org/10.1677/ERC-09-0028

Ejemplares similares